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are powerful tools to reveal microbial function in situ. This talk
will focus on how microbes can be studied at the single cell level
using molecular methods combined with two powerful chemical
imaging tools: nano-scale secondary ion mass spectrometry
(NanoSIMS) and Raman microspectroscopy. I will discuss how
isotope probing can be used to identify microbes that are utilizers
of specific compounds using foraging of secreted mucus by the
gut microbiota as an example. In order to identify intestinal
mucin- and mucosal-sugar degrading bacteria in situ, we devel-
oped stable isotope probing and single-cell analysis approaches
using NanoSIMS and Raman microspectroscopy coupled to
automated microfluidic sorting and post-measurement sequenc-
ing. We find that a diverse consortium of bacteria is involved in
mucin degradation, including several members of the underex-
plored “Candidatus Homeothermaceae” family, highlighting both
the complexity of this niche and the potential of Raman-based
sorting for identifying key players in targeted processes. We then
constructed a 5-species cocktail of commensals that reduce colo-
nization levels of the enteropathogen Clostridioides difficile by
competing for mucosal sugars, suggesting that this may be a
promising approach for rational design of bacteriotherapy.
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Secretory IgA (“SIgA”) is the only component of the adaptive
immune system present in the gut lumen, i.e. in the same physical
space as the intestinal microbiota. Whilst the specificity of
endogenous SIgA for the microbiota remains a hotly debated
topic, it is clear that oral vaccines can induce high-affinity, T-cell
dependent SIgA responses specific for vaccine-antigens. These
can protect the intestine, predominantly by driving enchained
growth and agglutination of bacteria deep in the gut lumen.
Large bacterial clumps generated cannot interact with the epithe-
lium and are rapidly cleared in the fecal stream. However, the
majority of protective SIgA in fact recognizes bacterial surface
glycans such as the O-antigens of lipopolysaccharide. As these
are highly repetitive and enzymatically generated, single point
mutations are sufficient to generate huge changes in glycan struc-
ture, and thus vaccine escape. Given the very large population
size of most gut bacterial species, within-host evolution is rapid
and inevitable. This has long been seen as the Achilles heel of
vaccines targeting bacterial surfaces, but in fact the very
inevitability of this evolution can be turned to our advantage:
Oral vaccines can be specifically designed to direct bacterial evo-
lution in the gut lumen. We have recently demonstrated this con-
cept to force the evolution of attenuation in Salmonella
typhimurium. "Evolutionary trap" vaccines therefore have the
potential to generate an overlooked form of non-sterilizing herd
immunity with major implications in clearing livestock reservoirs
of zoonotic and animal pathogens. We could also begin to imag-
ine more subtle applications of this technique for directed evolu-
tion of bacteria in the gut lumen. *The authors marked with an
asterisk equally contributed to the work.
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Gut microbiota responds to several environmental factors of which
nutrition is certainly among the most relevant. Health effects of
nutrients, both beneficial and hazardous, can be modified by
microbiota, while specific food components or dietary patterns
have the ability to shape microbiota and thereby impact health.
Traditionally, food–microbiota interactions are the most thor-
oughly studied for specific food components, such as probiotics
and prebiotics, while systemic health effects of the predominant,
beneficial carbohydrates’ metabolites – short-chain fatty acids
(SCFAs) – have been widely reported. Given the complexity of
both microbiota and food, it is clear that the interplay between
these two by far exceeds the effects of the predominant metabo-
lites. In contrast to carbohydrates fermentation, protein fermenta-
tion yields numerous, diverse, both health-promoting and health-
compromising compounds. In that respect, recently two protein
metabolites have been assigned to one pathology – type 2 diabetes
(T2D), in the opposite direction. In one study an inverse correla-
tion between the risk of T2D development and the abundance of a
microbial metabolite of the amino acid tryptophan (indolepropi-
onic acid) was established. Another microbiota metabolite, that is
produced starting from another amino acid – histidine (imidazole
propionate) – was found in increased levels in subjects suffering
from T2D. This metabolite impairs insulin signaling and is pro-
duced only in individuals with specific gut microbiota composition.
It has been widely shown that individual microbiota signature has
a tremendous impact on response to particular foods and, there-
fore, provides the basis for a personalized approach to nutrition.
Today, when technological developments have enabled detailed
microbiota assessment, this should be utilized to define nutritional
strategies with a beneficial effect on both Homo sapiens and micro-
biota as only such nutrition can confer long term health.
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Serotonin is a key neuromodulator of intestinal physiology. Sero-
tonin transporter (SERT) is responsible for serotonin uptake, mod-
ulating its availability and consequently, serotonergic signalling.
Recently, microbiota has been described to affect intestinal home-
ostasis through microbiota recognition receptors (TLRs). In fact,
TLRs activation seems to regulate intestinal serotonergic system.
However, whether intestinal microbiota can modulate SERT by
short-chain fatty acids (SCFA) is unknown. Microbiota-derived
short-chain fatty acids such as acetate, propionate and butyrate,
are important metabolites from non-digestible dietary fibers bacte-
rial fermentation. These metabolites have been shown to maintain
intestinal homeostasis through protecting epithelial barrier
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integrity, promoting IgA production and regulating T-cell differen-
tiation. In this study human enterocyte-like Caco-2/TC7 cells were
used as intestinal epithelial cells model, which expresses serotonin
transporter. Caco-2/TC7 cells were treated for 24 h with different
concentrations of acetate, propionate and butyrate and then, and
5-HT uptake was measured. SERT molecular expression was anal-
ysed by measuring both, mRNA levels by real-time PCR and pro-
tein expression by western blotting. Our results show that the
treatment with SCFA modulates SERT function and expression,
in a different way for each fatty acid. Consequently, a different
production of SCFA by microbiota could differently modulate
SERT and affect to serotonergic signalling and intestinal physiol-
ogy. Our study contributes to growing evidence about the key role
of microbiota on host physiology regulation, and it opens a cut-
ting-edge opportunity of microbiota modulation to balance sero-
tonergic signalling alterations.
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The spread of pathogenic antibiotic resistant bacteria in poultry
farms triggered the development of novel methods for maintain-
ing poultry health during its industrial production. The use of
probiotics in this field is promising. A new antimicrobial agent,
the ZP strain, was constructed: the bacteriocin ColE7 immunity
gene was inserted into the chromosome of the Escherichia coli
probiotic strain Nissle 1917 and a conjugative plasmid carrying
the colicin ColE7 activity gene was introduced into the strain
(Starcic Erjavec et al., 2015). The effect of ZP strain on 4 weeks
old rat (Wistar line), as well as on one-day old chicken (cross
ROSS 308) animal model systems after oral administration in the
drinking water at a dose of 5 9 108 and 5 9 1010 cell/ml/head
was studied. Intestinal microbiota, histology of the intestine,
spleen and Peyer’s patches, blood biochemistry, hematology,
microbicidal activity of leukocytes and macrophages, as well as
body weight were analyzed. Our results showed that the ZP
strain effectively colonized rat and chicken intestinal tract and
remained in the host animals at ~1–5 9 107 cell /g feces for 21
days. Further, our results showed that in the intestinal micro-
biota, the number of beneficial bacteria (lactic acid bacteria and
bifidobacteria) increased, while the number of pathogenic
microbes (staphylococci, pseudomonas, clostridia and fungi)
decreased, compared to controls with no ZP strain in the diet. In
addition, evidence was obtained that the ZP strain administered
in the drinking water was safe, exhibited a positive effect on local
and non-specific immune response of animals and led to weight
gain of rats. Thus, due to these beneficial effects revealed by the
used rat and chicken animal models the ZP strain may be consid-
ered an efficient potential probiotic for farm animals. The study
was carried out in the framework of the project No. C-26/792
supported financially by the Government of Perm Krai. *The
authors marked with an asterisk equally contributed to the work.
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Evolution of small RNA pathways in rodents
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Small RNA pathways are found in most eukaryotes and serve
multitutude roles. Mammals utilize three small RNA pathways:
PIWI-associated small RNA (piRNA) pathway, RNA interfer-
ence (RNAi) pathway and microRNA (miRNA) pathway. All
three pathways co-exist in mouse oocytes, which offer a unique
model for understanding their function and evolution. The
piRNA pathway functions in the germline where it recognizes
and suppresses mobile elements. It employs entirely different pro-
tein factors than the other two pathways and is non-essential in
the mouse female germline. RNAi is an ancient eukaryotic
defense mechanism against viruses and mobile elements. In mam-
mals, RNAi became a vestigial pathway, being surpassed during
vertebrate evolution by other innate and acquired immunity
mechanisms. The molecular mechanism for RNAi remains essen-
tially intact, but it used by the microRNA pathway, which regu-
lates endogenous gene expression. In mouse oocytes, RNAi
evolved into an essential mechanism thanks to a long terminal
repeat (LTR) insertion in a gene encoding Dicer, a factor pro-
ducing small RNAs acting in RNAi. This insertion occured in
the common ancestor of mice and hamsters and represents a
great example how LTRs remodeled gene expression and its con-
trol in the mouse germline during evolution. In fact, evolution of
the RNAi pathway in mice accommodated effects of dozens of
such insertions. The last pathway, the miRNA pathway, is
involved in control of gene expression. Genetic analysis showed
that maternal miRNAs are non-essential for oocyte growth and
development. This is apparently because unique constraints exist-
ing in the oocyte. My presentation will summarize our latest
results concerning mechanistical and functional overlaps of the
three pathways and will provide a revised insight into their (in)
significance in the female germline and beyond it.
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Exascale biology: from genome to climate
with a few stops along the way
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The cost of generating biological data is dropping exponentially,
resulting in increased data that has far outstripped the predictive
growth in computational power from Moore’s Law. This flood of
data has opened a new era of systems biology in which there are
unprecedented opportunities to gain insights into complex biologi-
cal systems. Integrated biological models need to capture the
higher order complexity of the interactions among cellular compo-
nents. Solving such complex combinatorial problems will give us
extraordinary levels of understanding of biological systems. These
exponentially increasing volumes of data, combined with the desire
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